Today sclerotherapy is the elective treatment for most cases of telangiectases. The main exceptions are "red" telangiectases, those with a caliber <0.3 mm and those with high flow, which do not respond to sclerotherapy or are aggravated by it as they require high concentrations of locally and generally toxic sclerosant solutions.
<bold>The aim of the study</bold> was to remove all types of telangiectases, reduce doses and concentrations of sclerosant drugs, reduce risks and side effects, improve course and recovery time and increase long-term effects.
<bold>Material and methods.</bold> We treated the types of telangiectases above-mentioned (563 cases on the legs, 375 on the face) with laser photocoagulation and two different techniques, called Laser-Video Sclerotherapy (LVST) and Laser-Video Therapy (LVT), utilizing also the videocapillaroscope coupled with diode laser 532 nm.
<bold>Results.</bold> All types of telangiectases of the face disappeared, and 22 cases only haven't results on the legs. Relapses had be minus than 10% of cases of legs, and minus than 7% on the face. No side effectives appears in any cases.
<bold>Conclusions.</bold> We achieved four on five objectives purposed, using LVT and LSVT in selected cases. Relapses are the greater problem still no-eliminated.
Financed by the National Centre for Research and Development under grant No. SP/I/1/77065/10 by the strategic scientific research and experimental development program:
SYNAT - “Interdisciplinary System for Interactive Scientific and Scientific-Technical Information”.